Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma
文献类型:期刊论文
作者 | Ye, Liuqing1,2,3,4; Zhou, Xi2; Lu, Jie2; Wang, Yanzhong2; Xie, Xinyou2,5; Zhang, Jun2,5![]() |
刊名 | JOURNAL OF CLINICAL LABORATORY ANALYSIS
![]() |
出版日期 | 2020-07-01 |
卷号 | 34 |
关键词 | calcitonin carcinoembryonic antigen lymph node metastasis medullary thyroid carcinoma neuron-specific enolase |
ISSN号 | 0887-8013 |
DOI | 10.1002/jcla.23278 |
通讯作者 | Xie, Xinyou(scottxie@mail.hz.zj.cn) ; Zhang, Jun(jameszhang2000@zju.edu.cn) |
英文摘要 | Background This study aimed to investigate the clinical application of combined detection of serum calcitonin (Ctn), carcinoembryonic antigen (CEA), and neuron-specific enolase (NSE) in predicting lateral lymph node metastasis (LLNM) in medullary thyroid carcinoma (MTC). Methods Seventy-four consecutive patients with MTC were enrolled. The relationship between serum Ctn, CEA, and NSE and LLNM was retrospectively analyzed by univariate analysis and logistic regression analysis. Furthermore, the clinical application of serum Ctn, CEA, and NSE combined detection in prediction of LLNM in MTC was also evaluated. Results The rate of LLNM in this study was 48.64% (36/74).The expression levels of serum Ctn, CEA, and NSE in MTC with LLNM were significantly higher than those without LLNM (allP < .01). The area under the curve (AUC) predicted by serum Ctn, CEA, and NSE for LLNM in MTC patients was 0.867, 0.831, and 0.726, respectively, and the AUC of serum Ctn, CEA, and NSE combined detection was up to 0.890, higher than using a single biomarker. The sensitivity and specificity of serum Ctn, CEA, and NSE combined detection in prediction of LLNM were 88.89% and 81.57%, respectively. Conclusions The concentrations of serum Ctn, CEA, and NSE are closely related to LLNM in MTC, and the combined detection of all three biomarkers has a higher clinical value in the evaluation of MTC patients with LLNM. With more perspective study in the future, it would be an indicator of influencing personalized surgical strategy for different MTC patients. |
WOS关键词 | FREE SURVIVAL ; BIOMARKER ; MANAGEMENT |
WOS研究方向 | Medical Laboratory Technology |
语种 | 英语 |
WOS记录号 | WOS:000551044400042 |
出版者 | WILEY |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/102979] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Xie, Xinyou; Zhang, Jun |
作者单位 | 1.Zhejiang Canc Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China 2.Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Clin Lab, Hangzhou 310016, Zhejiang, Peoples R China 3.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Zhejiang, Peoples R China 4.Univ Chinese Acad Sci, Canc Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China 5.Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou, Zhejiang, Peoples R China |
推荐引用方式 GB/T 7714 | Ye, Liuqing,Zhou, Xi,Lu, Jie,et al. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma[J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS,2020,34. |
APA | Ye, Liuqing,Zhou, Xi,Lu, Jie,Wang, Yanzhong,Xie, Xinyou,&Zhang, Jun.(2020).Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.JOURNAL OF CLINICAL LABORATORY ANALYSIS,34. |
MLA | Ye, Liuqing,et al."Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma".JOURNAL OF CLINICAL LABORATORY ANALYSIS 34(2020). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。